AU Stock MarketDetailed Quotes

Arovella Therapeutics Ltd (ALAO)

Watchlist
  • 0.016
  • +0.001+6.67%
20min DelayMarket Closed May 1 15:54 AET
19.34MMarket Cap0.00P/E (Static)

Arovella Therapeutics Ltd (ALAO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2025
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
(FY)Jun 30, 2018
(FY)Jun 30, 2017
(FY)Jun 30, 2016
Total revenue
700.00%136K
-95.81%17K
37.22%405.9K
14.95%295.81K
-51.69%257.35K
-56.30%532.69K
186.26%1.22M
-94.08%425.86K
24.40%7.2M
2.86%5.79M
Operating revenue
700.00%136K
-95.81%17K
37.22%405.9K
14.95%295.81K
-51.69%257.35K
-56.30%532.69K
186.26%1.22M
-94.08%425.86K
24.40%7.2M
2.86%5.79M
Cost of revenue
-1.71%203.52K
-7.05%207.06K
10.84%222.75K
0.64%200.97K
7.58%199.69K
-96.65%185.62K
9.24%5.54M
-4.94%5.07M
Gross profit
700.00%136K
-91.60%17K
128.02%202.38K
156.54%88.75K
-89.57%34.6K
-67.46%331.72K
324.32%1.02M
-85.49%240.24K
132.18%1.66M
147.15%713.31K
Operating expense
4.71%11.34M
9.56%10.83M
28.60%9.88M
63.49%7.69M
-8.32%4.7M
51.91%5.13M
-46.82%3.38M
104.86%6.35M
-6.63%3.1M
-24.06%3.32M
Selling and administrative expenses
10.42%3.06M
-21.65%2.77M
26.63%3.54M
33.41%2.79M
-3.29%2.09M
59.83%2.17M
-15.64%1.35M
-32.86%1.61M
-0.02%2.39M
-5.73%2.39M
-Selling and marketing expense
----
----
--433.4K
----
----
----
----
----
----
----
-General and administrative expense
10.42%3.06M
-10.71%2.77M
11.11%3.1M
33.41%2.79M
-3.29%2.09M
59.83%2.17M
-15.64%1.35M
-32.86%1.61M
-0.02%2.39M
-5.73%2.39M
Research and development costs
-3.17%6.52M
69.05%6.74M
53.46%3.98M
379.39%2.6M
136.71%541.55K
--228.78K
----
----
----
----
Depreciation amortization depletion
149.63%107.29K
-94.87%42.98K
51.80%837.18K
-15.44%551.49K
13.94%652.18K
21.49%572.38K
199.20%471.13K
26.73%157.46K
1.54%124.25K
-32.49%122.36K
-Depreciation and amortization
149.63%107.29K
-94.87%42.98K
51.80%837.18K
-15.44%551.49K
13.94%652.18K
21.49%572.38K
199.20%471.13K
26.73%157.46K
1.54%124.25K
-32.49%122.36K
Other operating expenses
29.00%1.65M
-16.13%1.28M
-12.58%1.52M
23.43%1.74M
-34.60%1.41M
39.47%2.16M
-66.20%1.55M
687.55%4.58M
-27.55%581.97K
-51.32%803.31K
Operating profit
-3.62%-11.2M
-11.68%-10.81M
-27.44%-9.68M
-62.80%-7.6M
2.70%-4.67M
-103.57%-4.8M
61.42%-2.36M
-323.52%-6.11M
44.64%-1.44M
36.17%-2.6M
Net non-operating interest income (expenses)
199.40%389.53K
1,292.08%130.1K
104.90%9.35K
-613.50%-190.88K
-220.30%-26.75K
123.59%22.24K
45.98%-94.26K
12.50%-174.5K
-61.16%-199.43K
-131.62%-123.74K
Non-operating interest income
180.77%389.53K
362.14%138.74K
680.75%30.02K
-41.23%3.85K
-84.97%6.54K
41.26%43.51K
1,118.03%30.8K
-89.47%2.53K
-72.01%24.02K
-16.50%85.81K
Non-operating interest expense
----
-58.25%8.63K
-89.38%20.67K
484.85%194.72K
406.76%33.29K
-94.75%6.57K
-29.36%125.06K
-20.77%177.03K
6.63%223.45K
34.16%209.56K
Total other finance cost
----
----
----
----
----
--14.71K
----
----
----
----
Other net income (expenses)
70.74%3.3M
479.47%1.94M
38.80%-509.96K
-134.99%-833.27K
93.91%-354.6K
7.21%-5.82M
-1,160.79%-6.27M
-27.82%-497.31K
-20.00%-389.09K
-431.57%-324.25K
Special income (charges)
----
----
-87.06%-1.56M
33.93%-833.27K
78.84%-1.26M
5.41%-5.96M
-1,025.44%-6.3M
-293.70%-559.94K
64.21%-142.22K
-7,385.00%-397.4K
-Less:Impairment of capital assets
----
----
87.06%1.56M
-32.77%833.27K
-79.12%1.24M
-5.40%5.94M
1,020.97%6.28M
609.26%559.94K
--78.95K
----
-Less:Other special charges
----
----
----
----
-7.65%21.8K
-5.57%23.61K
--25K
----
-84.08%63.28K
--397.48K
-Gain on sale of property,plant,equipment
----
----
----
----
----
----
----
----
----
-98.57%78
Other non-operating income (expenses)
70.74%3.3M
84.51%1.94M
--1.05M
----
534.70%906.67K
350.70%142.85K
-49.39%31.7K
125.37%62.63K
-437.48%-246.86K
-20.78%73.15K
Income before tax
14.14%-7.51M
14.10%-8.75M
-18.11%-10.18M
-70.79%-8.62M
49.24%-5.05M
-14.04%-9.94M
-28.65%-8.72M
-233.84%-6.78M
33.01%-2.03M
24.91%-3.03M
Income tax
0
0
0
0
0
0
-24.16%-925K
5.93%-745K
1.00%-792K
-21.60%-800K
Earnings from equity interest net of tax
Net income
14.14%-7.51M
14.10%-8.75M
-18.11%-10.18M
-70.79%-8.62M
49.24%-5.05M
-27.57%-9.94M
-42.79%-7.8M
-340.87%-5.46M
44.49%-1.24M
33.97%-2.23M
Net income continuous operations
14.14%-7.51M
14.10%-8.75M
-18.11%-10.18M
-70.79%-8.62M
49.24%-5.05M
-27.57%-9.94M
-29.20%-7.8M
-387.20%-6.03M
44.49%-1.24M
33.97%-2.23M
Net income discontinuous operations
----
----
----
----
----
----
----
--573.81K
----
----
Noncontrolling interests
Net income attributable to the company
14.14%-7.51M
14.10%-8.75M
-18.11%-10.18M
-70.79%-8.62M
49.24%-5.05M
-27.57%-9.94M
-42.79%-7.8M
-340.87%-5.46M
44.49%-1.24M
33.75%-2.23M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
14.14%-7.51M
14.10%-8.75M
-18.11%-10.18M
-70.79%-8.62M
49.24%-5.05M
-27.57%-9.94M
-42.79%-7.8M
-340.87%-5.46M
44.49%-1.24M
33.75%-2.23M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2025(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019(FY)Jun 30, 2018(FY)Jun 30, 2017(FY)Jun 30, 2016
Total revenue 700.00%136K-95.81%17K37.22%405.9K14.95%295.81K-51.69%257.35K-56.30%532.69K186.26%1.22M-94.08%425.86K24.40%7.2M2.86%5.79M
Operating revenue 700.00%136K-95.81%17K37.22%405.9K14.95%295.81K-51.69%257.35K-56.30%532.69K186.26%1.22M-94.08%425.86K24.40%7.2M2.86%5.79M
Cost of revenue -1.71%203.52K-7.05%207.06K10.84%222.75K0.64%200.97K7.58%199.69K-96.65%185.62K9.24%5.54M-4.94%5.07M
Gross profit 700.00%136K-91.60%17K128.02%202.38K156.54%88.75K-89.57%34.6K-67.46%331.72K324.32%1.02M-85.49%240.24K132.18%1.66M147.15%713.31K
Operating expense 4.71%11.34M9.56%10.83M28.60%9.88M63.49%7.69M-8.32%4.7M51.91%5.13M-46.82%3.38M104.86%6.35M-6.63%3.1M-24.06%3.32M
Selling and administrative expenses 10.42%3.06M-21.65%2.77M26.63%3.54M33.41%2.79M-3.29%2.09M59.83%2.17M-15.64%1.35M-32.86%1.61M-0.02%2.39M-5.73%2.39M
-Selling and marketing expense ----------433.4K----------------------------
-General and administrative expense 10.42%3.06M-10.71%2.77M11.11%3.1M33.41%2.79M-3.29%2.09M59.83%2.17M-15.64%1.35M-32.86%1.61M-0.02%2.39M-5.73%2.39M
Research and development costs -3.17%6.52M69.05%6.74M53.46%3.98M379.39%2.6M136.71%541.55K--228.78K----------------
Depreciation amortization depletion 149.63%107.29K-94.87%42.98K51.80%837.18K-15.44%551.49K13.94%652.18K21.49%572.38K199.20%471.13K26.73%157.46K1.54%124.25K-32.49%122.36K
-Depreciation and amortization 149.63%107.29K-94.87%42.98K51.80%837.18K-15.44%551.49K13.94%652.18K21.49%572.38K199.20%471.13K26.73%157.46K1.54%124.25K-32.49%122.36K
Other operating expenses 29.00%1.65M-16.13%1.28M-12.58%1.52M23.43%1.74M-34.60%1.41M39.47%2.16M-66.20%1.55M687.55%4.58M-27.55%581.97K-51.32%803.31K
Operating profit -3.62%-11.2M-11.68%-10.81M-27.44%-9.68M-62.80%-7.6M2.70%-4.67M-103.57%-4.8M61.42%-2.36M-323.52%-6.11M44.64%-1.44M36.17%-2.6M
Net non-operating interest income (expenses) 199.40%389.53K1,292.08%130.1K104.90%9.35K-613.50%-190.88K-220.30%-26.75K123.59%22.24K45.98%-94.26K12.50%-174.5K-61.16%-199.43K-131.62%-123.74K
Non-operating interest income 180.77%389.53K362.14%138.74K680.75%30.02K-41.23%3.85K-84.97%6.54K41.26%43.51K1,118.03%30.8K-89.47%2.53K-72.01%24.02K-16.50%85.81K
Non-operating interest expense -----58.25%8.63K-89.38%20.67K484.85%194.72K406.76%33.29K-94.75%6.57K-29.36%125.06K-20.77%177.03K6.63%223.45K34.16%209.56K
Total other finance cost ----------------------14.71K----------------
Other net income (expenses) 70.74%3.3M479.47%1.94M38.80%-509.96K-134.99%-833.27K93.91%-354.6K7.21%-5.82M-1,160.79%-6.27M-27.82%-497.31K-20.00%-389.09K-431.57%-324.25K
Special income (charges) ---------87.06%-1.56M33.93%-833.27K78.84%-1.26M5.41%-5.96M-1,025.44%-6.3M-293.70%-559.94K64.21%-142.22K-7,385.00%-397.4K
-Less:Impairment of capital assets --------87.06%1.56M-32.77%833.27K-79.12%1.24M-5.40%5.94M1,020.97%6.28M609.26%559.94K--78.95K----
-Less:Other special charges -----------------7.65%21.8K-5.57%23.61K--25K-----84.08%63.28K--397.48K
-Gain on sale of property,plant,equipment -------------------------------------98.57%78
Other non-operating income (expenses) 70.74%3.3M84.51%1.94M--1.05M----534.70%906.67K350.70%142.85K-49.39%31.7K125.37%62.63K-437.48%-246.86K-20.78%73.15K
Income before tax 14.14%-7.51M14.10%-8.75M-18.11%-10.18M-70.79%-8.62M49.24%-5.05M-14.04%-9.94M-28.65%-8.72M-233.84%-6.78M33.01%-2.03M24.91%-3.03M
Income tax 000000-24.16%-925K5.93%-745K1.00%-792K-21.60%-800K
Earnings from equity interest net of tax
Net income 14.14%-7.51M14.10%-8.75M-18.11%-10.18M-70.79%-8.62M49.24%-5.05M-27.57%-9.94M-42.79%-7.8M-340.87%-5.46M44.49%-1.24M33.97%-2.23M
Net income continuous operations 14.14%-7.51M14.10%-8.75M-18.11%-10.18M-70.79%-8.62M49.24%-5.05M-27.57%-9.94M-29.20%-7.8M-387.20%-6.03M44.49%-1.24M33.97%-2.23M
Net income discontinuous operations ------------------------------573.81K--------
Noncontrolling interests
Net income attributable to the company 14.14%-7.51M14.10%-8.75M-18.11%-10.18M-70.79%-8.62M49.24%-5.05M-27.57%-9.94M-42.79%-7.8M-340.87%-5.46M44.49%-1.24M33.75%-2.23M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 14.14%-7.51M14.10%-8.75M-18.11%-10.18M-70.79%-8.62M49.24%-5.05M-27.57%-9.94M-42.79%-7.8M-340.87%-5.46M44.49%-1.24M33.75%-2.23M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More